1. New pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4(3H)-one hybrids linked to arene units: synthesis of potential MRSA, VRE, and COX-2 inhibitors
- Author
-
Sanad, Sherif M.H. and Mekky, Ahmed E.M.
- Subjects
Pyrimidines -- Chemical properties ,Chemistry - Abstract
In the current study, we reported the tandem synthesis of two series of arene-linked pyrimidinone hybrids with related fused thieno[2,3-b]pyridine moiety. The target hybrids were prepared, in moderate to excellent yields, by the reaction of a ternary mixture of the appropriate of 3-aminothieno[2,3-b]pyridine-2-carboxylate, DMF-DMA, and a series of aryl amines in dioxane at 110 [degrees]C for 8 h. The antibacterial activity of the new hybrids was estimated against six susceptible ATCC strains. Hybrids 5g and 7g, linked to a sulfonamide unit, showed the best efficacy against S. aureus and E. faecalis strains with minimum inhibitory concentration (MIC) values of 1.7-1.8 [micro]M, which exceed ciprofloxacin. Furthermore, some of new hybrids were examined as potential inhibitors of four different MRSA and VRE strains. Hybrids 5g and 7g demonstrated more potent efficacy than linezolid against MRSA strains with MIC values of 3.6/3.4 and 1.8/1.7 [micro]M against ATCC:33591 and ATCC:43300 strains, respectively. The prior hybrids displayed a comparable efficacy with linezolid against VRE strains with MIC values of 7.3/6.9 and 3.6/3.4 [micro]M against ATCC:51299 and ATCC:51575 strains, respectively. Additionally, some of the new hybrids were examined as potential COX-2 inhibitors using the reference celecoxib ([IC.sub.50] of 0.117 [micro]M). Hybrid 7g revealed more potent inhibitory efficacy than celecoxib with [IC.sub.50] of 0.112 [micro]M, whereas hybrid 5g showed almost inhibitory activity equivalent to celecoxib with [IC.sub.50] of 0.121 [micro]M. Molecular docking was performed to predict the possible binding interactions between hybrids 5g and 7g with the target COX-2 enzyme. Key words: COX-2 inhibitor, MRSA inhibitor, multi-component reaction, pyrido[3'2'45]thieno[32-d]pyrimidine, VRE inhibitor. La presente etude decrit la synthese en tandem de deux series d'hybrides de pyrimidinones liees a un arene dont la partie thieno[2,3b]pyridine est fusionnee. Nous avons prepare les hybrides cibles, avec des rendements moderes a excellents, par reaction d'un melange ternaire contenant le 3aminothieno[2,3b]pyridine-2carboxylate correspondant, du dimethylformamide-dimethylacetal (DMFDMA) et une serie d'arylamines dans le dioxane a 110 [degrees]C pendant 8 h. L'activite antibacterienne des nouveaux hybrides a ete evaluee contre six souches ATCC sensibles. Les hybrids 5g et 7g, lies a une unite sulfonamide, ont montre la meilleure efficacite contre les souches de S. aureus et E. faecalis, avec des concentrations minimales inhibitrices (CMI) de 1,7 a 1,8 [micro]M, ce qui surpasse l'efficacite de la ciprofloxacine. De plus, nous avons evalue certains des nouveaux hybrides comme possibles inhibiteurs de quatre souches differentes de SARM et d'ERV. Les hybrids 5g et 7g ont montre une meilleure efficacite que le linezolide contre les souches de SARM, avec des CMI de 3,6/3,4 [micro]M et de 1,8/1,7 [micro]M contre les souches ATCC:33591 et ATCC:43300, respectivement. Les hybrides anterieurs avaient montre une efficacite comparable a celle du linezolide contre les souches d'ERV, avec des CMI de 7,3/6,9 [micro]M et de 3,6/3,4 [micro]M contre les souches ATCC:51299 et ATCC:51575, respectivement. De plus, nous avons evalue certains des nouveaux hybrides comme possibles inhibiteurs de la COX2 en utilisant le celecoxib comme reference ([CI.sub.50] de 0,117 [micro]M). L'hybride 7g s'est revele etre un inhibiteur plus puissant que le celecoxib, sa [CI.sub.50] etant de 0,112 [micro]M, tandis que l'hybride 5g a montre une activite inhibitrice presque equivalente a celle du celecoxib, avec une [CI.sub.50] de 0,121 [micro]M. Nous avons soumis les hybrids 5g et 7g auneexperience d'amarrage moleculaire afin de predire leurs eventuelles interactions de liaison avec l'enzyme COX2 cible. [Traduit par la Redaction] Mots-cles : inhibiteur de COX2, inhibiteur de SARM, reaction a composants multiples, pyrido[3',2'4,5]thieno[3,2d]pyrimidine, inhibiteur d'ERV., Introduction The worldwide threat to current antibiotics of antimicrobial resistance has grown in recent years. (1-4) Globally, antimicrobial resistance is estimated to cause more than 700 thousand deaths per year. [...]
- Published
- 2021
- Full Text
- View/download PDF